How Much Weight Do You Lose on Wegovy?

Last reviewed: June 28, 2026

Last updated: June 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has demonstrated significant weight loss results in clinical trials, with participants losing an average of 15 pounds over 12 weeks and up to 50+ pounds over one year when combined with diet and exercise. However, individual outcomes depend on multiple factors including your genetic makeup, metabolic rate, and adherence to the treatment protocol. PlexusDx uses precision genetic testing to optimize your semaglutide therapy and predict which pathways will respond best to treatment.

Typical Semaglutide Weight Loss Results in Clinical Studies

Clinical trials show that semaglutide injection produces measurable weight reduction within the first month, with most patients experiencing steady progress through months 2–4. The STEP program, which studied semaglutide efficacy, found that participants on the 2.4 mg dose lost an average of 35 pounds (about 15% of body weight) over 68 weeks compared to 6 pounds in the placebo group. This difference becomes more pronounced as treatment continues, with some patients reaching 40–50 pound losses by month 12.

Your individual weight loss trajectory depends on starting weight, baseline metabolism, and how your body responds to the medication. Patients with higher starting weights often see larger absolute pound losses, though percentage-based loss tends to cluster around 10–22% across all weight categories. PlexusDx tracks your progress monthly and adjusts your protocol if needed to keep you on track toward your goal.

Factors That Influence Your Personal Weight Loss Outcome

Genetic variation in the GLP-1 receptor and other appetite-control pathways significantly impacts how much weight you will lose on semaglutide. The Precision Peptide Genetic Test from PlexusDx analyzes 14 metabolic pathways and over 150 genetic insights to identify which compounds and dosages align with your biology. Key variants like GLP1R rs6923761 and GIPR rs1800437 affect medication responsiveness and can predict whether you'll be an early responder or require longer to reach optimal dosing.

Beyond genetics, lifestyle factors including daily calorie intake, physical activity level, sleep quality, and stress management directly shape your results. Patients who combine semaglutide with consistent strength training and adequate protein intake often achieve 20–30% greater weight loss than those on medication alone. PlexusDx recommends setting realistic 12-month goals and tracking non-scale victories like improved energy, better blood sugar control, and clothes fitting differently.

How Dosage Progression Affects Weight Loss on Semaglutide

Semaglutide injection begins at a low dose (0.25 mg) and increases every four weeks to minimize side effects and allow your body to adapt. Most patients reach the therapeutic dose of 2.0–2.4 mg by week 16–20, and weight loss accelerates as you move through the dosage ramp. The cumulative effect means that months 3–6 typically show the most dramatic results, with continued progress through month 12 and beyond.

Your dose may need to go up based on your response and tolerance, but your price won't—PlexusDx keeps compounded semaglutide injection at one flat rate starting at $149 per month across all commitment tiers. This pricing model removes the financial barriers that traditionally discourage patients from reaching their optimal therapeutic dose. If you plateau after reaching your target dose, your PlexusDx provider may recommend the Precision Peptide Genetic Test to identify whether adding a complementary compound or adjusting your protocol would help restart progress.

Maintaining Weight Loss After Reaching Your Goal

Research shows that weight regain occurs rapidly if semaglutide is stopped without addressing underlying metabolic and behavioral factors. Patients who discontinue the medication typically regain 50% of lost weight within one year, underscoring the importance of long-term treatment plans. PlexusDx supports maintenance through ongoing medication access, periodic genetic insights updates, and lifestyle coaching to lock in results.

The most successful long-term outcomes combine semaglutide with durable changes to eating patterns, movement, and stress management. Many PlexusDx patients find that after 6–12 months on medication, their appetite regulation improves to the point that maintaining their new weight becomes easier even with smaller portions of the medication. Your PlexusDx provider will work with you to develop a sustainable maintenance strategy that may include dose adjustment, addition of complementary compounds, or incorporation of newer peptide options like tirzepatide if your genetic profile suggests added benefit.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in my first month on semaglutide?

Most patients lose 2–5 pounds in the first four weeks while on the starting dose of 0.25 mg, though some experience minimal change initially. Weight loss accelerates as your dose increases every four weeks and your body adjusts to the medication's appetite-suppressing effects. PlexusDx tracks your progress monthly and ensures your dosing schedule keeps you moving toward your goal.

Is 15% weight loss typical for semaglutide, or can I lose more?

The STEP trials showed 15% average loss, but individual results range from 10–22% depending on genetics, adherence, and lifestyle. PlexusDx's Precision Peptide Genetic Test identifies your genetic predispositions for weight loss response, helping predict whether you'll be in the higher-responder category or may benefit from combination therapy with tirzepatide for enhanced results.

Why is compounded semaglutide from PlexusDx cheaper than name-brand Wegovy?

PlexusDx sources semaglutide from licensed 503A compounding pharmacies, which produce medications at lower cost than brand manufacturers without sacrificing quality or efficacy. Compounded semaglutide injection starts at $149 per month, and you pay one flat rate regardless of your dose level—no insurance required, HSA/FSA eligible, and available in all 50 states.

Is it safe to use semaglutide long-term, or should I stop after reaching my goal weight?

Semaglutide is designed for long-term use and remains safe when monitored by a healthcare provider, though individual tolerance and goals vary. Stopping suddenly often leads to rapid weight regain, so PlexusDx recommends discussing a sustainable maintenance strategy with your provider rather than abrupt discontinuation. Some patients benefit from lower maintenance doses or transition to newer peptides based on their genetic profile.

How does the Precision Peptide Genetic Test help me lose more weight?

The test ($99 after your first month) analyzes 14 metabolic pathways and 150+ genetic insights, including variants in the GLP-1 receptor and appetite-control genes like FTO and MC4R. These results predict your likely response to semaglutide, identify whether tirzepatide or dual-compound GLP-Squared might accelerate results, and guide your provider in creating a truly personalized protocol instead of a one-size-fits-all approach.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Wegovy For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.